At Talis we strive for excellence in all we do.

Talis

Adjective –
talis (neuter tale); third declension; latin
distinguished; great; excellent

Team

Brian Coe

Chief Executive Officer, Co-founder

Brian Coe, CEO. Mr. Coe founded and served as CEO of Litholink Corporation which was acquired by LabCorp. He has served as an adjunct Professor of Entrepreneurship at Chicago Booth. Mr. Coe earned an M.B.A. from Chicago Booth and a B.A. in Neuroscience and Psychology from Brandeis University.

Martin Goldberg, Ph.D.

Sr. Vice President of Research and Development

Marty Goldberg, Ph.D., SVP R&D, began his career at IBM Corporation at the TJ Watson Research Center and East Fishkill working on photoimageable dielectric coatings, he then was at Affymetrix for 17 years, eventually serving as an SVP and head of R&D. Dr. Goldberg subsequently served as COO at Gen9. Dr. Goldberg holds a Ph.D. in Chemistry from the University of California at San Diego.

Sobha Pisharody, Ph.D.

Senior Vice President,Product and Strategy

Sobha Pisharody, Ph.D., SVP of Product and Strategy, was a Director of Product Management at Thermo Fisher Scientific where she led businesses within the qPCR and Capillary Electrophoresis franchises. Prior to that Dr. Pisharody was the founder and CEO of GenoRx, Inc. She holds a Ph.D. in Molecular Oncology and Immunology from the New York University School of Medicine and a B.S. in Genetics from the University of California at Berkeley.

Karen E. Flick, J.D., Ph.D.

Vice President, Legal

Karen Flick, Ph.D., J.D., VP, legal, has over 20 years of experience developing, pursuing and managing intellectual property assets for biotechnology, pharmaceutical and diagnostics enterprises. Prior to joining Talis, she practiced patent law as an associate at several leading law firms in the Bay Area and as an independent counsel. Dr. Flick earned her J.D. in Law and a Ph.D. in Molecular and Cell Biology from the University of California at Berkeley and holds A.B. in Biochemical Sciences from Harvard College.

Rainer Ziermann, Ph.D.

VP Medical and Scientific Affairs

Rainer Ziermann, Ph.D., VP Medical and Scientific Affairs, has more than 20 years of experience in the Biotechnology/Diagnostics industry with increasing responsibilities in R&D, Scientific, Clinical, and Regulatory Affairs. As VP Clinical Affairs at Cepheid and subsequently in the same role at Hologic, he had responsibilities for the successful development, design, and execution of clinical trial and regulatory submission strategies for a variety of molecular diagnostic infectious disease and blood screening products. Dr. Ziermann graduated with a Master’s degree from the Ludwig-Maximilians-University at Munich/Germany, carried out his Ph.D. work at UC Berkeley, and completed a postdoctoral fellowship at UC San Francisco.

Marilee Moy

VP, HR

Marilee Moy, VP, HR, has over 25 years of Human Resources experience in life sciences and technology industries, ranging from start-ups through publicly traded organizations. Prior to joining Talis, she led human resources at Counsyl. She has held HR leadership positions at Genentech, Abbott Laboratories, Johnson & Johnson and Nikon Precision. She holds a BA from Boston College, an MBA from Golden Gate University, and strategic human resources executive certification from the University of Michigan.

Thomas Cauley III “Trey”, Ph.D.

Vice President,Engineering

Thomas H. Cauley, Ph.D., VP of Engineering, joined Talis from BioRad R&D, where he was a System Engineer developing digital droplet PCR systems following its acquisition of QuantaLife where he was a key engineer in the development of the Automated Droplet Generator. Before that Dr. Cauley worked at several medical device and molecular diagnostic startups in the bay area. Dr. Cauley received his Ph.D. in Mechanical Engineering from the University of California at Berkeley, and a BS in ME from Iowa State University.

Hedia Maamar, Ph.D.

Vice President, Molecular Biology

Hedia Maamar, Ph.D., VP of Molecular Biology, has extensive expertise on the biology of microorganisms and the tools to study them. Positions at the Public Health Research Institute, U. of Central Florida and U. of Pennsylvania led to several publications in high impact journals with over 1,000 citations. Dr. Maamar received a Ph.D. and M.S. in Molecular Microbiology and Biotechnologies from Aix Marseille University in France and a Bachelor of Bioengineering from National School of Engineers Sfax in Tunisia.

Mojgan Haddad, Ph.D.

Senior Director, Informatics and Software

Mojgan Haddad, Ph.D., Senior Director of Informatics and Software, was the Sr. Director of Analytics at HealthTell and prior to that, was at Monogram Biosciences, a LabCorp company, for 14 years. At Monogram, Dr. Haddad held roles of increasing responsibility, including Director of Bioinformatics and Biostatistics, and Director of Software Engineering. Dr. Haddad received her Ph.D. in Computer Science, and her Masters in Computer Science/Artificial Intelligence from Vienna University of Technology in Austria, and completed a postdoctoral fellowship at UC San Francisco.

Margaret Barrett, M.S.

Sr. Director of Accounting & Finance

Maggie Barret, M.S., Sr. Director of Accounting & Finance was in the Financial Reporting department of AMP and was the Director of Finance and Accounting at Offerpop in New York City. Previously Ms. Barret worked at KPMG for 6 years, transferring to the Sydney, Australia office in 2010. Ms. Barret received her M.S./B.S. in Accounting from the University of Connecticut.

Liang Li, Ph.D.

Director, Technology Strategy, Co-founder

Liang Li, Ph.D. Director of Technology Strategy, conducted postdoctoral academic research at the University of Chicago, focusing on development of microfluidic platforms and their applications in protein crystallization and biochemical assays. He published 19 papers in high-impact journals with over 1,000 citations. He is a co-inventor on multiple patents, including several Talis related patents. Dr. Li received his Ph.D. in Chemistry at University of Chicago and a B.S./M.S. in Chemistry from Nanjing University.

Marc Valer, M.B.A.

Director of Product Management

Marc Valer, M.B.A., Director of Product Management served 16 years at Agilent Technologies/Hewlett Packard where he held several marketing management positions leading product lines in Genomics, Automation and Microfluidics. Mr. Valer's international experience includes positions in the United States, Germany, the Netherlands and Spain. Mr. Valer received his M.B.A. from the University of California at Berkeley and a B.S. in Chemistry from the Autonomous University of Barcelona in Spain.

Lori Lai, M.B.A., D.H.Sc.

Director of Product Management

Lori Lai, Director of Product Management, has acquired her 20+ years of clinical diagnostic product expertise at companies such as Dako, Novartis Diagnostics and Quest Diagnostics. She has served as the commercial lead on core teams responsible for the development of infectious disease products including an HIV drug resistance genotyping system. Her international experience includes management positions in Japan and Hong Kong. Dr. Lai has earned a B.S. in Medical Technology, an M.B.A. in Entrepreneurship and Finance from the University of Chicago, and a Doctor of Health Sciences degree.

Board of Directors

BRIAN COE, M.B.A. Chief Executive Officer, Co-founder

RUSTEM ISMAGILOV, Ph.D., Co-founder

RANDY SCOTT, Ph.D.

MATT POSARD

FELIX BAKER, Ph.D

News

PR
October 11, 2018

Talis Biomedical Corporation announces expansion of Scientific Advisory Board

Talis Biomedical Corporation announces expansion of Scientific Advisory Board   Dr. Jane Schwebke, MD, joins the Talis SAB https://portal.prnewswire.com/HandleOrder/ExternalHome.aspx?level1=1
PR
August 29, 2018

Talis Biomedical Corporation awarded $5.6M by NIH

Talis Biomedical Corporation awarded $5.6M by NIH To fund development of clinically impactful Point-of-Care diagnostics for Antimicrobial-Resistant Bacteria   https://www.prnewswire.com/news-releases/talis-biomedical-corporation-awarded-5-6m-by-nih-300664593.html
PR
August 29, 2018

Talis Bio awarded $4.4M by CARB-X

Talis Biomedical Corporation awarded $4.4M by CARB-X To fund development of rapid point-of-care diagnostic tests for pathogen identification and antibiotic susceptibility https://www.prnewswire.com/news-releases/talis-biomedical-corporation-awarded-4-4m-by-carb-x-300646438.html  
Read More

Join Our Team

See Opportunities

Talis Technology

Learn More